|
SUCLG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.17019999976453E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.75099999949668E-07 |
| Normal-vs-Stage2 |
4.65679999994695E-06 |
| Normal-vs-Stage3 |
1.08779999996589E-06 |
| Normal-vs-Stage4 |
3.744100000036E-06 |
| Stage1-vs-Stage2 |
7.532600E-01 |
| Stage1-vs-Stage3 |
9.879200E-01 |
| Stage1-vs-Stage4 |
4.766000E-01 |
| Stage2-vs-Stage3 |
8.068400E-01 |
| Stage2-vs-Stage4 |
4.214000E-01 |
| Stage3-vs-Stage4 |
5.185600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.89850000001479E-07 |
| Normal-vs-AfricanAmerican |
3.25850000004735E-06 |
| Normal-vs-Asian |
6.824300E-02 |
| Caucasian-vs-AfricanAmerican |
1.800970E-01 |
| Caucasian-vs-Asian |
2.225000E-01 |
| AfricanAmerican-vs-Asian |
4.835000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.79179999954182E-07 |
| Normal-vs-Female |
7.1108999999403E-07 |
| Male-vs-Female |
9.068200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.27409999906814E-08 |
| Normal-vs-Extreme_Weight |
1.903999999886E-07 |
| Normal-vs-Obese |
7.98389999667748E-08 |
| Normal-vs-Extreme_Obese |
3.013700E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.269600E-01 |
| Normal_Weight-vs-Obese |
2.749400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.115350E-01 |
| Extreme_Weight-vs-Obese |
5.101400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.490980E-01 |
| Obese-vs-Extreme_Obese |
2.242600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.777900E-03 |
| Normal-vs-Age(41-60Yrs) |
2.98639999951611E-07 |
| Normal-vs-Age(61-80Yrs) |
4.95009999990081E-07 |
| Normal-vs-Age(81-100Yrs) |
5.19580000024611E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.451200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.197800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.456200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.482600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.688400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.855200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.77700000053771E-07 |
| Normal-VS-Type2 PRCC |
3.28530000004434E-06 |
| Normal-VS-KIRP CIMP |
9.55390000001444E-07 |
| Normal-VS-Unclassified PRCC |
1.32770000005333E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.954410E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.524980E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.558000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.068300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.600600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.442230E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.75910000016688E-07 |
| Normal-vs-N1 |
2.36609999999526E-05 |
| Normal-vs-N2 |
3.263300E-03 |
| N0-vs-N1 |
6.040000E-01 |
| N0-vs-N2 |
1.375600E-01 |
| N1-vs-N2 |
2.567800E-01 |
|
|
